Clinical Pharmacology Practice Questions

Q: A patient on low-molecular-weight heparin suddenly develops a severe hemorrhage. What test would be most useful to assess the degree of anticoagulation?

Stop LMWH immediately. ***Stop LMWH immediately*** - The immediate priority in severe hemorrhage due to **low-molecular-weight heparin (LMWH)** is to cease further administration of the anticoagulant. [1] - This prevents worsening of the bleeding by halting the delivery of more drug that could contribute to the **anticoagulant effect**, thus allowing natural clotting mechanisms to begin recovery. [1] *Administer protamine sulfate* - While **protamine sulfate** is a reversal agent for LMWH, its efficacy is only partial (about 60-75% neutralization of anti-Xa activity) compared to its effect on unfractionated heparin. - Therefore, it is a secondary step after stopping the drug itself and may not fully reverse the severe hemorrhage. *Transfuse blood products* - **Transfusion of blood products** (e.g., packed red blood cells, fresh frozen plasma, platelets) addresses the consequences of severe hemorrhage (e.g., anemia, coagulopathy) but does not directly neutralize the anticoagulant effect of LMWH. - This is a supportive measure, crucial for managing blood loss and maintaining hemodynamic stability, but not the primary action to stop the drug's effect. *Consider specific reversal agents* - **Specific reversal agents** for LMWH itself are limited; protamine sulfate is the primary option, albeit with partial efficacy. - Newer agents for direct oral anticoagulants might be considered in other contexts, but for LMWH, stopping the drug is the most immediate and universally applicable action.

Q: What is the MOST COMMON side effect of vagal nerve stimulation?

voice changes. ***voice changes*** - **Voice changes**, such as **hoarseness** or dysphonia, are the most frequently reported side effect due to the proximity of the stimulator to the **recurrent laryngeal nerve** [1]. - These changes often occur during stimulation and can be managed by adjusting the device settings. *coughing* - While **coughing** can occur, it is a less common side effect compared to voice changes. - It results from irritation of the **laryngeal or pharyngeal branches** of the vagus nerve. *nausea* - **Nausea** is a less common side effect and typically occurs due to activation of the **gastrointestinal afferent fibers** of the vagus nerve [2]. - It usually resolves with adjustment of stimulation parameters or over time. *throat discomfort* - **Throat discomfort** or pain can occur, but it is less frequent than voice changes and may be associated with the surgical implantation site or local irritation from the lead. - It is distinct from the functional changes in voice caused by direct nerve stimulation.

Q: A 45-year-old woman who underwent a modified radical mastectomy 4 years ago and was treated for multiple bone metastases with cyclophosphamide, doxorubicin, and fluorouracil for 6 months is complaining of exertional dyspnea, swelling of the legs, and periorbital edema in the morning. On examination, she has bilateral rales in the lungs, and her cardiovascular examination reveals a palpable S1, S2, S3, and S4 gallop. Her blood pressure is 149/117 mmHg, pulse rate is 80/min, and respiratory rate is 18/min. What is the most likely cause of her cardiac condition?

Drug induced cardiac toxicity. ***Drug induced cardiac toxicity*** - The patient's history of treatment with **doxorubicin**, an **anthracycline**, is a significant risk factor for **dose-dependent cardiotoxicity**, which can manifest years after cessation of therapy. [1] - Symptoms like **exertional dyspnea**, **leg swelling**, **periorbital edema**, and findings such as **rales**, **hypertension**, and gallop rhythms (**S3 and S4**) are consistent with **heart failure** secondary to cardiotoxicity. [1] *Cardiac involvement from metastasis or heart failure* - While metastatic disease can involve the heart, it's less common for it to present as isolated **cardiac dysfunction** without other prominent metastatic symptoms, especially 4 years post-treatment. - Heart failure is present, but **drug toxicity** is the more specific and likely underlying cause given her treatment history, rather than a general term like "cardiac involvement from metastasis." *Pneumonia* - Although **rales** are present, there is no mention of fever, cough with sputum, or leukocytosis, which are typical signs of **pneumonia**. - The chronicity of symptoms (dyspnea, edema) and the presence of **S3 and S4 gallops** are more indicative of a **chronic cardiac condition** than an acute infection. [1] *Systolic dysfunction due to heart failure secondary to drug toxicity* - This option is partially correct but less comprehensive than "Drug induced cardiac toxicity." While **systolic dysfunction** and **heart failure** are consequences, "drug induced cardiac toxicity" is the direct and primary cause. [1] - The question asks for the "most likely cause of her cardiac condition," and the toxicity itself is the etiology leading to the dysfunction and failure.

Q: What is the etiology of the rash in a 20-year-old college student who presented with fever, sore throat, and malaise, and was previously diagnosed with streptococcal pharyngitis and treated with intramuscular ampicillin, despite having no history of travel?

Exanthematous drug eruption. ***Exanthematous drug eruption*** - This patient's history of **ampicillin administration** for streptococcal pharyngitis, followed by the development of a rash, points strongly to an **exanthematous drug eruption** [1]. - **Ampicillin** and amoxicillin are known to cause a maculopapular rash in patients with **Epstein-Barr virus (EBV) infection**, which can present with similar symptoms to streptococcal pharyngitis (fever, sore throat, malaise), making this the most likely scenario [1]. *Parvovirus B19 infection* - **Parvovirus B19** causes **Fifth disease**, characterized by a "slapped cheek" rash on the face and a lacy rash on the trunk and extremities, which is not described. - While it can cause fever and malaise, the preceding **streptococcal pharyngitis** and **ampicillin use** make a drug reaction more probable. *Chikungunya virus infection* - **Chikungunya virus** typically presents with severe **arthralgia**, fever, and rash, often in patients with recent travel to endemic areas. - The patient has no history of travel, and **arthralgia** is not mentioned as a primary symptom. *Measles infection* - **Measles** presents with a characteristic **maculopapular rash** that starts on the face and spreads downwards, often preceded by **Koplik spots**. - While measles causes fever and malaise, the diagnosis of **streptococcal pharyngitis** and subsequent **ampicillin use** strongly suggest a drug-induced rash rather than measles.

Q: All are used for management of hyperkalemia except?

ACE inhibitors. ***ACE inhibitors*** - **ACE inhibitors** (Angiotensin-Converting Enzyme inhibitors) are a common cause of **hyperkalemia** because they block the production of aldosterone, which normally promotes potassium excretion [1]. - Therefore, ACE inhibitors would worsen hyperkalemia rather than treat it. *Insulin plus dextrose* - **Insulin** drives potassium into cells, thereby lowering serum potassium levels; **dextrose** is given concurrently to prevent hypoglycemia [1]. - This is a rapid and effective treatment for acute hyperkalemia, especially in emergent situations [1]. *Beta 2 agonist* - **Beta-2 adrenergic agonists** (e.g., albuterol) stimulate the sodium-potassium pump, promoting the intracellular shift of potassium. - This effect helps to decrease extracellular potassium levels, making it a viable treatment option for hyperkalemia. *Calcium gluconate* - **Calcium gluconate** does not lower serum potassium levels but stabilizes the cardiac cell membrane potential, reducing the risk of arrhythmias caused by hyperkalemia [1]. - It is often the first-line treatment in hyperkalemic emergencies with ECG changes [1].

Question 1

A patient on low-molecular-weight heparin suddenly develops a severe hemorrhage. What test would be most useful to assess the degree of anticoagulation?

Accepted Answer

Stop LMWH immediately

Answer

Transfuse blood products

Answer

Administer protamine sulfate

Answer

Consider specific reversal agents

Question 2

What is the MOST COMMON side effect of vagal nerve stimulation?

Accepted Answer

voice changes

Answer

nausea

Answer

coughing

Answer

throat discomfort

Question 3

A 45-year-old woman who underwent a modified radical mastectomy 4 years ago and was treated for multiple bone metastases with cyclophosphamide, doxorubicin, and fluorouracil for 6 months is complaining of exertional dyspnea, swelling of the legs, and periorbital edema in the morning. On examination, she has bilateral rales in the lungs, and her cardiovascular examination reveals a palpable S1, S2, S3, and S4 gallop. Her blood pressure is 149/117 mmHg, pulse rate is 80/min, and respiratory rate is 18/min. What is the most likely cause of her cardiac condition?

Accepted Answer

Drug induced cardiac toxicity

Answer

Pneumonia

Answer

Cardiac involvement from metastasis or heart failure

Answer

Systolic dysfunction due to heart failure secondary to drug toxicity

Question 4

What is the etiology of the rash in a 20-year-old college student who presented with fever, sore throat, and malaise, and was previously diagnosed with streptococcal pharyngitis and treated with intramuscular ampicillin, despite having no history of travel?

Accepted Answer

Exanthematous drug eruption

Answer

Parvovirus B19 infection

Answer

Chikungunya virus infection

Answer

Measles infection

Question 5

All are used for management of hyperkalemia except?

Accepted Answer

ACE inhibitors

Answer

Insulin plus dextrose

Answer

Beta 2 agonist

Answer

Calcium gluconate

Clinical Pharmacology — MCQs

Clinical Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?